hexamethonium has been researched along with ANS (Autonomic Nervous System) Diseases in 3 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FREIS, ED | 1 |
| Osborn, JW | 2 |
| Collister, JP | 1 |
| Guzman, P | 1 |
| Santajuliana, D | 1 |
| Zukowska-Grojec, Z | 1 |
3 other studies available for hexamethonium and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Veratrum viride and hexamethonium in the treatment of severe diastolic hypertension.
Topics: Autonomic Nervous System Diseases; Bis-Trimethylammonium Compounds; Blood Pressure; Blood Pressure D | 1951 |
Effect of peripheral sympathetic nerve dysfunction on salt sensitivity of arterial pressure.
Topics: Animals; Antihypertensive Agents; Autonomic Nervous System Diseases; Blood Pressure; Dose-Response R | 2008 |
Contribution of alpha- and beta- adrenoceptors and neuropeptide-Y to autonomic dysreflexia.
Topics: Animals; Autonomic Nervous System Diseases; Blood Pressure; Ganglionic Blockers; Heart Rate; Hexamet | 1995 |